Botswana vs Eswatini: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Botswana
1.1%
in 2024
Eswatini
1.2%
in 2024
Botswana rank
29th
Eswatini rank
28th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Botswana
- Eswatini
How they compare
Eswatini currently reports 1.2% against 1.1% in Botswana, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Botswana's.
Across all 10 years both countries report, Eswatini has been ahead every year.
Botswana ranks 29th and Eswatini ranks 28th of 247 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Botswana | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.5% | 0.1% | Eswatini |
| 2020s | 1.2% | 1.4% | 0.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Botswana or Eswatini?
- Eswatini, at 1.2% against 1.1% in Botswana as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Botswana and Eswatini?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Botswana and Eswatini?
- 10 years are reported by both, from 2015 to 2024.
- How do Botswana and Eswatini rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Botswana ranks 29th and Eswatini ranks 28th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.